Skip to content

A Randomized Controlled Clinical Study on the Application of Multidimensional Compound Nutritional Powder Combined with Wheat Cellulose Granules in Rapid Rehabilitation After Mixed Hemorrhoid Surgery

A Randomized Controlled Clinical Study on the Application of Multidimensional Compound Nutritional Powder Combined with Wheat Cellulose Granules in Rapid Rehabilitation After Mixed Hemorrhoid Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125785
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative of mixed hemorrhoids

Interventions

Control group:On the 7th day after surgery, follow a regular low-residue diet (porridge, noodles, eggs, etc.) and avoid vegetables, fruits, meat and other similar foods.
Treatment group:Consume multi-dimensional compound nutrition powder within 1 to 2 days after surgery. Take 6 sachets in divided doses from breakfast to dinner, 2 sachets each time. Mix with approximat

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years, no gender restriction 2. Postoperative period of mixed hemorrhoids 3. Research participants shall participate voluntarily and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Intolerant individuals 2. Patients with a history of surgical intestinal resection 3. Pregnant and lactating women 4. Those allergic to any ingredients of this product 5. Digestive and absorptive dysfunction 6. Dietary restrictions due to other reasons 7. Patients suffering from intestinal obstruction, constipation, inflammatory bowel disease, anal fistula, perianal abscess, Crohn's disease, rectal prolapse and other anorectal diseases 8. Patients with severe cardiac, respiratory, neurological or mental disorders 9. Participants currently enrolled in other clinical trials

Design outcomes

Primary

MeasureTime frame
Grade 4 Rating Scale: Bleeding Severity, Defecation Effort, Defecation Time, Defecation Frequency, Anal Tenesmus, Abdominal Distension Incidence, VAS Pain Score, Edema, Urinary Retention, Stool Consistency;Hospitalization Time;Defecation status;

Secondary

MeasureTime frame
Taste of Test Product;Odor of Test Product;Satiety of Test Product;Overall Patient Satisfaction;

Countries

China

Contacts

Public ContactChengwei Ruan

The Affiliated Hospital of Xuzhou Medical University

doctorruan666@163.com+86 516 8580 2179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026